| ・ | Watanabe H, Oshima T: The Latest Treatments for Cancer Cachexia: An Overview. Anticancer Res 43(2): 511-521, 2023. |
| ・ | Kumazu Y, Hasegawa S, Hayashi T, Yamada T, Watanabe H, Hara K, Shimoda Y, Nakazono M, Nagasawa S, Rino Y, Masuda M, Ogata T, Oshima T, Yoshikawa T: Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction? Eur J Surg Oncol 49(1): 76-82, 2023. |
| ・ | Nakazono M, Aoyama T, Komori K, Watanabe H, Kano K, Nagasawa S, Segami K, Tamagawa H, Yukawa N, Rino Y, Ogata T, Oshima T: The Comparison of the Dietary Intake Loss Between Elderly and Non-Elderly Patients After Gastrectomy for Gastric Cancer. J Gastrointest Cancer 54(1): 35-43, 2023. |
| ・ | Aoyama T, Nakazono M, Segami K, Nagasawa S, Kano K, Hara K, Maezawa Y, Hashimoto I, Suematsu H, Watanabe H, Komori K, Tamagawa H, Yukawa N, Rino Y, Ogata T, Oshima T: Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment. J Gastrointest Cancer 54(1): 27-34, 2023. |
| ・ | Onuma S, Hashimoto I, Suematsu H, Nagasawa S, Kanematsu K, Aoyama T, Yamada T, Rino Y, Ogata T, Oshima T: Clinical Effects of the Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients with Gastric Cancer after Gastrectomy. J Pers Med 13(3): 432 ,2023. |
| ・ | Hashimoto I, Kano K, Onuma S, Suematsu H, Nagasawa S, Kanematsu K, Furusawa K, Hamagushi T, Watanabe M, Hayashi K, Furuta M, Inokuchi Y, Machida N, Aoyama T, Yamada T, Rino Y, Ogata T and Oshima T: Clinical significance of neutrophil-to-lymphocyte ratio/serum albumin ratio in patients with metastatic gastric or gastroesophageal junction cancer administered trifluridine/tipiracil. Anticancer Res 43(4): 1689-1697, 2023. |
| ・ | Aoyama T, Hashimoto I, Oshima T: The Clinical Impact of the Tumor Stroma Ratio in Gastrointestinal Cancer Treatment. Anticancer Res 43(5): 1877-1883, 2023. |
| ・ | Nagasawa S, Oshima T, Hara K, Nakazono M, Kumazu Y, Aoyama T, Yamada T, Ogata T, Rino Y, Saito A, Yokose T, Grabsch HI: Clinical Significance of Pre-treatment Circumferential Tumor Location in Patients With cStage IB-III Esophageal Squamous Cell Cancer. Anticancer Res 43(6): 2697-2705, 2023. |
| ・ | Komori K, Kano K, Ando S, Watanabe H, Takahashi K, Maezawa Y, Fujikawa H, Sawazaki S, Numata M, Aoyama T, Yamada T, Tamagawa H, Yukawa N, Rino Y, Ogata T, Oshima T: Clinicopathological Characteristics and Prognosis of Mucinous Gastric Cancer. Anticancer Res 43(6): 2865-2871, 2023. |
| ・ | Hashimoto I, Kano K, Onuma S, Suematsu H, Nagasawa S, Kanematsu K, Furusawa K, Hamaguchi T, Watanabe M, Hayashi K, Furuta M, Inokuchi Y, Machida N, Aoyama T, Yamada T, Rino Y, Ogata T, Oshima T: Clinical effect of the C-reactive protein to serum albumin ratio in patients with metastatic gastric or gastroesophageal junction cancer treated with trifluridine/tipiracil, J Pers Med 13(6): 923, 2023. |
| ・ | Watanabe H, Hasegawa S, Kumazu Y, Hashimoto I, Komori K, Suematsu H, Kano K, Fujikawa H, Aoyama T, Yamada T, Yukawa N, Yoshikawa T, Rino Y, Saito A, Ogata T, Oshima T: Can Clinical Stage in the 8th Edition of the Union for International Cancer Control TNM Classification Stratify the Prognosis of Patients Undergoing Curative Surgery for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction? In Vivo 37(4): 1790-1796, 2023. |
| ・ | Aoyama T, Maezawa Y, Hashimoto I, Rino Y, Oshima T : Clinical Impact of Nutrition and Inflammation Assessment Tools in Pancreatic Cancer Treatment. Anticancer Res. 43(9):3849-3860, 2023. |
| ・ | Watanabe H, Kano K, Hashimoto I, Tanabe M, Onuma S, Morita J, Nagasawa S, Kanematsu K, Aoyama T, Yamada T, Ogata T, Rino Y, Saito A, Oshima T: Intraoperative Blood Loss Impacts Recurrence and Survival in Patients With Locally Advanced Esophageal Cancer. Anticancer Res 43(11): 5173-5179, 2023. |
| ・ | Aoyama T, Hashimoto I, Maezawa Y, Hara K, Komori K, Otani K, Kazama K, Sawazaki S, Numata M, Kamiya N, Kato A, Yamada T, Nagasawa S, Kawahara S, Cho H, Morita J, Tanabe M, Yukawa N, Saito A, Rino Y, Ogata T, Oshima T : The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor for Patients With Gastric Cancer Who Receive Curative Surgery. Anticancer Res 43(11): 5181-5187, 2023. |
| ・ | Aoyama T, Maezawa Y, Hashimoto I, Hara K, Komori K, Otani K, Kazama K, Sawazaki S, Numata M, Kawahara S, Cho H, Morita J, Segami K, Tanabe M, Yukawa N, Saito A, Rino Y, Ogata T, Oshima T: The clinical impact of change in the C-reactive protein/albumin ratio in gastric cancer patients who receive curative treatment. J Gastrointest Cancer. Online ahead of print. 2023. |
| ・ | Aoyama T, Hashimoto I, Maezawa Y, Hara K, Kazama K, Numata M, Otani K, Sawazaki S, Cho H, Morita J, Kawahara S, Tanabe M, Yukawa N, Saito A, Ogata T, Rino Y, Oshima T : The Clinical Impact of Change in the Neutrophil to Lymphocyte Ratio During the Perioperative Period in Gastric Cancer Patients Who Receive Curative Gastrectomy. J Gastrointest Cancer. Online ahead of print. 2023. |
| ・ | Veldhuizen GP, Röcken C, Behrens HM, Cifci D, Muti HS, Yoshikawa T, Arai T, Oshima T, Tan P, Ebert MP, Pearson AT, Calderaro J, Grabsch HI, Kather JN: Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study. Gastric Cancer 26(5): 708-720, 2023. (共同研究) |
| ・ | Shitara K, Rha SY, Wyrwicz LS, Oshima T, Karaseva N, Osipov M, Yasui H, Yabusaki H, Afanasyev S, Park YK, Al-Batran SE, Yoshikawa T, Yanez P, Dib Bartolomeo M, Lonardi S, Tabernero J, Van Cutsem E, Janjigian YY, Oh DY, Xu J, Fang X, Shih CS, Bhagia P, Bang YJ; KEYNOTE-585 investigators. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study. Lancet Oncol 19: S1470-2045(23)00541-7, 2023. (共同研究) |
| ・ | Natsume H, Szczepaniak K, Yamada H, Iwashita Y, Gędek M, Šuto J, Ishino K, Kasajima R, Matsuda T, Manirakiza F, Nzitakera A, Wu Y, Xiao N, He Q, Guo W, Cai Z, Ohta T, Szekely T, Kadar Z, Sekiyama A, Oshima T, Yoshikawa T, Tsuburaya A, Kurono N, Wang Y, Miyagi Y, Gurzu S, Sugimura H. Non-CpG sites preference in G:C > A:T transition of TP53 in gastric cancer of Eastern Europe (Poland, Romania and Hungary) compared to East Asian countries (China and Japan). Genes Environ 45(1): 1, 2023. (共同研究) |
| ・ | Shitara K, Hirao M, Iwasa S, Oshima T, Komatsu Y, Kawazoe A, Sato Y, Hamakawa T, Yonemori K, Machida N, Yuki S, Suzuki T, Okumura S, Takase T, Semba T, Zimmermann B, Teng A, Yamaguchi K. Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort. Clin Cancer Res 29(8):1460-1467, 2023. (共同研究) |
| ・ | Shitara K, Yamaguchi K, Muro K, Yasui H, Sakai D, Oshima T, Fujimura M, Sato Y, Yamazaki S, Wakabayashi T, Sugihara M, Kamio T, Shoji H. Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study. Int J Clin Oncol 29(1): 27-35, 2023. (共同研究) |
| ・ | Suematsu H, Kano K, Yamada T, Hashimoto I, Watanabe H, Takahashi K, Watanabe M, Hayashi K, Kaneta Y, Furuta M, Inokuchi Y, Machida N, Aoyama T, Tamagawa H, Yukawa N, Rino Y, Masuda M, Ogata T, Oshima T. Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab. Anticancer Res. 2022 Mar;42(3):1535-1540. |
| ・ | Yasuhiro Inokuchi, Ayaka Ishida, Kei Hayashi, Yoshihiro Kaneta, Hayato Watanabe, Kazuki Kano, Mitsuhiro Furuta, Kosuke Takahashi, Hirohito Fujikawa, Takanobu Yamada, Kouji Yamamoto, Nozomu Machida, Takashi Ogata, Takashi Oshima, Shin Maeda. Feasibility of gastric endoscopic submucosal dissection in elderly patients aged 80 years. World J Gastrointest Endosc. 2022 Jan 16;14(1):49-62. |
| ・ | Hashimoto I, Oshima T. Claudins and Gastric Cancer: An Overview. Cancers (Basel) 2022 Jan 7;14(2):290. |
| ・ | Masato Nakazono, Toru Aoyama, Keisuke Komori, Hayato Watanabe, Kazuki Kano, Shinsuke Nagasawa, Kenki Segami, Hiroshi Tamagawa, Norio Yukawa, Yasushi Rino, Takashi Ogata, Takashi Oshima. The Comparison of the Dietary Intake Loss Between Elderly and Non-Elderly Patients After Gastrectomy for Gastric Cancer. J Gastrointest Cancer 2022 Jan 3. doi: 10.1007/s12029-021-00776-x. Online ahead of print. |
| ・ | Yoko Matsuda, Taro Yamashita, Juanjuan Ye, Mami Yasukawa, Keiko Yamakawa, Yuri Mukai, Mitsuhiro Machitani, Yataro Daigo, Yohei Miyagi, Tomoyuki Yokose, Takashi Oshima, Hiroyuki Ito, Soichiro Morinaga, Takeshi Kishida, Toshinari Minamoto, Shinji Yamada, Junko Takei, Mika K Kaneko, Motohiro Kojima, Shuichi Kaneko, Tsutomu Masaki, Masahiro Hirata, Reiji Haba, Keiichi Kontani, Nobuhiro Kanaji, Nobuyuki Miyatake, Keiichi Okano, Yukinari Kato, Kenkichi Masutomi. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs. Thol 2022 Jan 30. doi: 10.1002/path.5876. Online ahead of print.（共同研究） |
| ・ | Aoyama T, Komori K, Nakazano M, Hara K, Tamagawa H, Kazama K, Hashimoto I, Yamada T, Maezawa Y, Segami K, Kano K, Nagasawa S, Yukawa N, Rino Y, Ogata T, Oshima T. The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment.
|
| ・ | Komori K, Kano K, Yamada T, Watanabe H, Takahashi K, Maezawa Y, Fujikawa H, Numata M, Aoyama T, Tamagawa H, Yukawa N, Rino Y, Masuda M, Ogata T, Oshima T.Usefulness of Surgical Staging of Gastric Cancer in Neoadjuvant Chemotherapy Candidates: A Single-center Retrospective Study.
|
| ・ | Aoyama T, Nakazano M, Nagasawa S, Hara K, Komori K, Tamagawa H, Maezawa Y, Segami K, Kano K, Ogata T, Yukawa N, Rino Y, Oshima T The Association of the Lymphocyte-to-C-Reactive-Protein Ratio With Gastric Cancer Patients Who Receive Curative Treatment.
|
| ・ | Silva ANS, Saito Y, Yoshikawa T, Oshima T, Hayden JD, Oosting J, Earle S, Hewitt LC, Slaney HL, Wright A, Inam I, Langley RE, Allum W, Nankivell MG, Hutchins G, Cunningham D, Grabsch HI. Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
|
| ・ | Oshima T, Tsuburaya A, Yoshida K, Yoshikawa T, Miyagi Y, Rino Y, Masuda M, Guan J, Tan P, Grabsch HI, Sakamoto J, Tanaka S. Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial. Sci Rep. May 20;12(1):8509, 2022. |
| ・ | Watanabe H, Kano K, Hashimoto I, Suematsu H, Aoyama T, Yamada T, Ogata T, Rino Y, Oshima T. Clinical Significance of Mean Corpuscular Volume in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma. In Vivo. Sep-Oct;36(5):2371-2378, 2022. |
| ・ | Komori K, Kano K, Aoyama T, Hara K, Nagasawa S, Nakazono M, Shimoda Y, Maezawa Y, Kumazu Y, Kawabe T, Numata M, Hayashi T, Yamada T, Tamagawa H, Sato T, Cho H, Yukawa N, Rino Y, Yoshikawa T, Ogata T, Oshima T. Clinical Impact of Surgical Sarcopenia on Long-term Survival. Anticancer Res. Sep;42(9):4545-4552, 2022. |
| ・ | Kumazu Y, Hasegawa S, Hayashi T, Yamada T, Watanabe H, Hara K, Shimoda Y, Nakazono M, Nagasawa S, Rino Y, Masuda M, Ogata T, Oshima T, Yoshikawa T. Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction? Eur J Surg Oncol. Jul 9:S0748-7983(22)00550-9, 2022. |
| ・ | Aoyama T, Maezawa Y, Cho H, Saigusa Y, Tamura J, Tsuchida K, Komori K, Kano K, Segami K, Hara K, Senuki K, Suzuki Y, Yamakawa M, Tamagawa H, Oshima T, Yukawa N, Rino Y. Phase II Study of a Multi-center Randomized Controlled Trial to Evaluate Oral Vitamin B12 Treatment for Vitamin B12 Deficiency After Total Gastrectomy in Gastric Cancer Patients. Anticancer Res. Aug;42(8):3963-3970, 2022. |
| ・ | Suematsu H, Hashimoto I, Hiroshima Y, Watanabe H, Kano K, Takahashi K, Aoyama T, Yamada T, Tamagawa H, Ogata T, Yukawa N, Rino Y, Masuda M, Miyagi Y, Oshima T. Clinical Significance of EREG Gene Expression in Gastric Cancer Tissue After Curative Surgery. Anticancer Res. Aug;42(8):3873-3878, 2022. |
| ・ | Aoyama T, Komori K, Tamagawa A, Nakazano M, Hara K, Hashimoto I, Tamagawa H, Segami K, Maezawa Y, Kano K, Oshima T, Yukawa N, Rino Y. Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment. In Vivo. Mar-Apr;36(2):994-1000, 2022. |
| ・ | Aoyama T, Maezawa Y, Cho H, Saigusa Y, Tamura J, Tsuchida K, Komori K, Kano K, Segami K, Hara K, Senuki K, Suzuki Y, Yamakawa M, Tamagawa H, Oshima T, Yukawa N, Rino Y. Phase II Study of a Multi-center Randomized Controlled Trial to Evaluate Oral Vitamin B12 Treatment for Vitamin B12 Deficiency After Total Gastrectomy in Gastric Cancer Patients. Anticancer Res. Aug;42(8):3963-3970, 2022. |
| ・ | Silva ANS, Saito Y, Yoshikawa T, Oshima T, Hayden JD, Oosting J, Earle S, Hewitt LC, Slaney HL, Wright A, Inam I, Langley RE, Allum WH, Nankivell MG, Hutchins G, Cunningham D, Grabsch HI. Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma. Br J Surg. Aug 16;109(9):e106, 2022.（共同研究） |
| ・ | Yamada T, Hayashi T, Fujikawa H, Kumazu Y, Nagasawa S, Nakazono M, Kano K, Hara K, Watanabe H, Komori K, Shimoda Y, Takahashi K, Ogata T, Oshima T, Yoshikawa T. Feasibility and Safety of Oral Nutritional Supplementation with High-Density Liquid Diet After Total Gastrectomy for Gastric Cancer. World J Surg. Oct;46(10):2433-2439, 2022. |
| ・ | Sundar R, Barr Kumarakulasinghe N, Huak Chan Y, Yoshida K, Yoshikawa T, Miyagi Y, Rino Y, Masuda M, Guan J, Sakamoto J, Tanaka S, Tan AL, Hoppe MM, Jeyasekharan AD, Ng CCY, De Simone M, Grabsch HI, Lee J, Oshima T, Tsuburaya A, Tan P. Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial. Gut. Apr;71(4):676-685, 2022.（共同研究） |
| ・ | Yamaguchi K, Minashi K, Sakai D, Nishina T, Omuro Y, Tsuda M, Iwagami S, Kawakami H, Esaki T, Sugimoto N, Oshima T, Kato K, Amagai K, Hosaka H, Komine K, Yasui H, Negoro Y, Ishido K, Tsushima T, Han S, Shiratori S, Takami T, Shitara K. Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer. Cancer Sci. Aug;113(8):2814-2827, 2022.（共同研究） |
| ・ | Iwasaki K, Cho H, Maezawa Y, Tsuchida K, Kano K, Fujikawa H, Yamada T, Ogata T, Oshima T. Assessment of the use of computed tomography colonography in early detection of peritoneal metastasis in patients with gastric cancer: A prospective cohort study. PLoS One. Jan 25;17(1):e0261527, 2022. |
| ・ | Shimoda Y, Fujikawa H, Keisuke Komori K, Watanabe H, Kano K, Yamada T, Shiozawa M, Morinaga S, Kenji Katsumata K, Tsuchida A, Ogata T, Oshima T. Preoperative utility of the Glasgow Prognostic Score on outcomes of patients with locally advanced gastric cancer. J Gastrointest Cancer. 2021 Jan 18. doi: 10.1007/s12029-021-00584-3. Online ahead of print. |
| ・ | Kano K, Yamada T, and Oshima T. ASO Author Reflections: Lymph Node Staging of Patients with Remnant Gastric Cancer. Ann Surg Oncol. 2021 May;28(5):2877-2878. |
| ・ | Kano K, Yamada T, Yamamoto K, Komori K, Watanabe H, Takahashi K, Fujikawa H, Aoyama T, Numata M, Tamagawa H, Yukawa N, Rino Y, Masuda M, Ogata T, Oshima T. The Impact of Pretherapeutic Naples Prognostic Score on Survival in Patients with Locally Advanced Esophageal Cancer. Ann Surg Oncol. 2021 Aug;28(8):4530-4539. |
| ・ | Kano K, Yamada T, Yamamoto K, Komori K, Watanabe H, Takahashi K, Maezawa Y, Fujikawa H, Numata M, Aoyama T, Tamagawa H, Cho H, Yukawa N, Yoshikawa T, Rino Y, Masuda M, Ogata T, Oshima T. Evaluation of Lymph Node Staging Systems as Independent Prognosticators in Remnant Gastric Cancer Patients with an Insufficient Number of Harvested Lymph Nodes. Ann Surg Oncol. 2021 May;28(5):2866-2876. |
| ・ | Watanabe H, Yamada T, Komori K, Hara K, Kano K, Takahashi K, Kumazu Y, Hujikawa H, Numata M, Aoyama T, Tamagawa H, Inokuchi Y, Machida N, Shiozawa M, Yukawa N, Morinaga N, Rino Y, Masuda M, Ogata T and Oshima T. Effect of Prognostic Nutrition Index in Gastric or Gastro-oesophageal Junction Cancer Patients Undergoing Nivolumab Monotherapy. In Vivo 2021 35(1)：563-569. |
| ・ | Kano K, Yamada T, and Oshima T. ASO Author Reflections: The Impact of Pretherapeutic Naples Prognostic Score on Survival in Patients with Locally Advanced Esophageal Cancer. Ann Surg Oncol. 2021 Aug;28(8):4540-4541. |
| ・ | Shimoda Y, Fujikawa H, Keisuke Komori K, Watanabe H, Kano K, Yamada T, Shiozawa M, Morinaga S, Kenji Katsumata K, Tsuchida A, Ogata T, Oshima T. Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery. Anticancer Res. 2021 41: 1005-1012. |
| ・ | Shimoda Y, Fujikawa H, Komori K, Watanabe H, Kano K, Yamada T, Shiozawa M, Morinaga S, Katsumata K, Tsuchida A, Ogata T, Oshima T: Glasgow Prognostic Score before curative resection may predict postoperative complications in patients with gastric cancer. J Gastrointest Cancer. 2021 Sep 14. doi: 10.1007/s12029-021-00689-9. Online ahead of print. PMID: 34519976 |
| ・ | Watanabe H, Fujikawa H, Komori K, Kano K, Takahashi K, Yamada Takanobu, Yasuhiro Inokuchi Y, Machida N, Yokose T, Rino Y, Masuda M, Takashi Ogata T, Oshima T. Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third- Case Reports in Gastroenterology 2021 June, 15(2):562-567. |
| ・ | Yamada T, Kano K, Fujikawa H, Komori K, Watanabe H, Shimoda Y, Shiozawa M, Morinaga S, Aoyama T, Numata M, Tamagawa H, Rino Y, Masuda M, Ogata T, Oshima T. Is sufficient experience performing open gastrectomies necessary to start laparoscopic distal gastrectomy training? Asian J Endosc Surg. 2021; 14(3): 489-495. |
| ・ | Watanabe T, Shiozawa M, Kimura Y, Hiroshima Y, Hashimoto I, Komori K, Watanabe H, Kano K, Fujikawa H, Aoyama T, Numata M, Yamada T, Tamagawa H, Ogata T, Yukawa N, Morinaga S, Rino Y, Masuda M, Miyagi Y, Oshima T. Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer. Anticancer Res. 2021; 41(4): 2117-2122. |
| ・ | Hatori S, Sakamaki K, Yokohori T, Kimura Y, Hiroshima Y, Hashimoto I, Komori K, Watanabe H, Kano K, Fujikawa H, Aoyama T, Numata M, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Shizawa M, Yukawa N, Morinaga S, Rino Y, Masuda M, Saeki H, Miyagi Y, Oshima T. Clinical Significance of PLA2G2A Expression in Gastric Cancer Patients who Receive Gastrectomy and Adjuvant S-1. Anticancer Res. 2021 Jul; 41(7): 3583-3588. |
| ・ | Segami K, Aoyama T, Hiroshima Y, Komori K, Hashimoto I, Hayato W, Watanabe H, Kano K, Nagasawa S, Nakazono M, Maezawa Y, Fujikawa H, Numata M, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Shiozawa M, Yukawa N, Morinaga S, Rino Y, Masuda M, Miyagi Y, Saeki H, Oshima T. Clinical Significance of TAP1 and DLL4 Expression in Patients With Locally Advanced Gastric Cancer. In Vivo 2021; 35(5): 2771-2777. |
| ・ | Aoyama T, Nakazono M, Segami K, Nagasawa S, Kano K, Hara K, Maezawa Y, Hashimoto I, Suematsu H, Watanabe H, Komori K, Tamagawa H, Yukawa N, Rino Y, Ogata T, Oshima T. Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment. J Gastrointest Cancer. 2021 Dec 18. doi: 10.1007/s12029-021-00777-w. Online ahead of print. |
| ・ | Aoyama T, Nakazono M, Segami K, Nagasawa S, Hara K, Tamagawa H, Komori K, Suematsu H, Maezawa Y, Kano K, Hashimoto I, Yamada T, Sato T, Numata M, Yukawa N, Ogata T, Rino Y, Oshima T. Safety and Feasibility of Gastrectomy for Gastric Cancer in Patients Receiving Antiplatelet and/or Anticoagulation Treatment. Anticancer Res. 2021 Nov;41(11):5605-5610. |
| ・ | Aoyama T, Nakazono M, Segami K, Nagasawa S, Kano K, Yamada T, Maezawa Y, Hara K, Hashimoto I, Suematsu H, Watanabe H, Takahashi K, Numata M, Tamagawa H, Yukawa N, Rino Y, Ogata T, Oshima T. The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer. In Vivo. 2021 Nov-Dec;35(6):3475-3482. |
| ・ | Nakazono M, Aoyama T, Hayashi T, Hara K, Segami K, Shimoda Y, Nagasawa S, Kumazu Y, Yamada T, Tamagawa H, Shiozawa M, Morinaga S, Rino Y, Masuda M, Ogata T, Oshima T. Comparison of the Dietary Intake Loss Between Total and Distal Gastrectomy for Gastric Cancer. In Vivo. 2021; 35(4): 2369-2377. |
| ・ | Nagasawa S, Tuchida K, Oshima T. Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients with Colorectal Cancer. Anticancer Res. 2021; 41(9): 4489-4495. |
| ・ | Ito Y, Fujitani K, Sakamaki K, Ando M, Kawabata R, Tanizawa Y, Yoshikawa T, Yamada T, Hirao M, Yamada M, Hihara J, Fukushima R, Choda Y, Kodera Y, Teshima S, Shinohara H, Kondo M: QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study. Gastric Cancer. 2021 Sep;24(5):1131-1139.（共同研究） |
| ・ | Tsuchida K, Sato T, Aoyama T, Atsumi Y, Kano K, Maezawa Y, Kazama K, Numata M, Yamada T, Tamagawa H, Murakami H, Oshima T, Saeki H, Cho H, Yukawa N, Yamamoto Y, Masuda M, Rino Y: Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer. Jpn J Clin Oncol. 51(3): 371-378, 2021.（共同研究） |
| ・ | Murakami H, Yamada T, Taguri M, Hasegawa S, Yamanaka T, Rino Y, Mushiake H, Oshima T, Matsukawa H, Tani K, Suzuki Y, Ozawa Y, Tanabe H, Osaragi T, Sato T, Tamagawa H, Yukawa N, Yoshikawa T, Imada T, Masuda M, Yamamoto Y: Short-Term Outcomes from a Randomized Screening Phase II Non-inferiority Trial Comparing Omentectomy and Omentum Preservation for Locally Advanced Gastric Cancer: the TOP-G Trial. World Journal of Surgery, 45(6):1803-1811, 2021.（共同研究） |
| ・ | Takahashi M, Kato K, Okada M, Chin K, Kadowaki S, Hamamoto Y, Doki Y, Kubota Y, Kawakami H, Ogata T, Hara H, Muto M, Nakashima Y, Ishihara R, Tsuda M, Motoyama S, Kodani M, Kitagawa Y: Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3). Esophagus, 18(1): 90–99, 2021.（共同研究） |
| ・ | Yang HK, Ji J, Han SU, Terashima M, Li G, Kim HH , Law S, Shabbir A, Song KY, Hyung WJ, Kosai NR, Kono K, Misawa K, Yabusaki H, Kinoshita T, Lau PC, Kim YW, Rao JR, Ng E, Yamada T, Yoshida K, Park DJ, Tai BC, So JBY, EXPEL study group: Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial. The Lancet Gastroenterology & Hepatology 2021 6(2): 120-127, 2021.（共同研究） |
| ・ | Rino Y, Aoyama T, Atsumi Y, Yamada T, Yukawa N: Metabolic bone disorders after gastrectomy: inevitable or preventable? Surgery Today 2021. doi: 10.1007/s00595-021-02253-1. Online ahead of print.（共同研究） |
| ・ | Sundar R, Barr Kumarakulasinghe N, Huak Chan Y, Yoshida K, Yoshikawa T, Miyagi Y, Rino Y, Masuda M, Guan J, Sakamoto J, Tanaka S, Tan AL, Hoppe MM, Jeyasekharan AD, Ng CCY, De Simone M, Grabsch HI, Lee J, Oshima T, Tsuburaya A, Tan P. Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial. Gut. 2021 May 12: gutjnl-2021-324060.（共同研究） |
| ・ | Atsumi Y, Rino Y, Aoyama T, Okuda N, Kawahara S, Kazama K, Numata M, Tamagawa H, Oshima T, Yukawa N, Masuda M. A Gender Comparison of Bone Metabolic Changes After Gastric Cancer Surgery: A Prospective Observational Study. In Vivo. 2021 Jul-Aug;35(4):2341-2348.（共同研究） |
| ・ | Muti HS, Heij LR, Keller G, Kohlruss M, Langer R, Dislich B, Cheong JH, Kim YW, Kim H, Kook MC, Cunningham D, Allum WH, Langley RE, Nankivell MG, Quirke P, Hayden JD, West NP, Irvine AJ, Yoshikawa T, Oshima T, Huss R, Grosser B, Roviello F, d'Ignazio A, Quaas A, Alakus H, Tan X, Pearson AT, Luedde T, Ebert MP, Jäger D, Trautwein C, Gaisa NT, Grabsch HI, Kather JN. Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study. Lancet Digit Health. 2021: S2589-7500(21)00133-3. Online ahead of print.（共同研究） |
| ・ | Tsuburaya A, Guan J, Yoshida K, Kobayashi M, Yoshino S, Tanabe K, Yoshikawa T, Oshima T, Miyashita Y, Sakamoto J, Tanaka S. Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials. Gastric Cancer. 2021 Aug 7. doi: 10.1007/s10120-021-01228-y. Online ahead of print.PMID: 34365541 Review.（共同研究） |
| ・ | Oshima T, Yoshikawa T, Miyagi Y, Morita S, Yamamoto M, Tanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y, Yokose T, Hiroshima Y, Aoyama T, Hayashi T, Ogata T, Cho H, Rino Y, Masuda M, Tsuburaya A, Sakamoto J. Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial. Oncotarget. 2020 Jul 28;11(30):2906-2918. |
| ・ | Hashimoto I, Oue N, Kimura Y, Hiroshima Y, Hara K, Maezawa Y, Kano K, Fujikawa H, Aoyama T, Numata M, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Shiozawa M, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T. Clinical Significance of Glioma-associated Oncogene 1 Expression in Patients With Locally Advanced Gastric Cancer Administered Adjuvant Chemotherapy With S-1 After Curative Surgery. Anticancer Res. 2020 Oct;40(10):5815-5821. |
| ・ | Hara K, Hayashi T, Nakazono M, Nagasawa S, Shimoda Y, Kumazu Y, Yamada T, Yamamoto N, Shiozawa M, Morinaga S, Yoshikawa T, Rino Y, Masuda M, Ogata T, Oshima T. An easy and reliable method to close Petersen's defect using barbed suture to prevent internal hernia from developing after gastrectomy with Roux-en-Y reconstruction.Asian J Endosc Surg. 2020 Apr;13(2):238-241. |
| ・ | Komori K, Kano K, Aoyama T, Hashimoto I, Hara K, Murakawa M, Atsumi Y, Maezawa Y, Kazama K, Numata M, Tamagawa H, Yukawa N, Oshima T, Masuda M, Rino Y. The Short- and Long-term Outcomes of Gastrectomy in Elderly Patients With Gastric Cancer. In Vivo. 2020;34(5):2697-2703. |
| ・ | Yoshikawa T, Aoyama T, Sakamaki K, Oshima T, Lin J, Zhang S, Sapari NS, Soong R, Tan I, Chan XB, Bottomley D, Hewitt LC, Arai T, Teh BT, Epstein D, Ogata T, Kameda Y, Miyagi Y, Tsuburaya A, Morita S, Grabsch HI, Tan P. Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer. J Cancer. 2019 Aug 28;10(21):5130-5138.（共同研究） |
| ・ | Meier A, Nekolla K, Hewitt LC, Earle S, Yoshikawa T, Oshima T, Miyagi Y, Huss R, Schmidt G, Grabsch HI. Hypothesis-free deep survival learning applied to the tumour microenvironment in gastric cancer. J Pathol Clin Res. 2020 Oct;6(4):273-282.（共同研究） |
| ・ | Kerckhoffs KGP, Liu DHW, Saragoni L, van der Post RS, Langer R, Bencivenga M, Iglesias M, Gallo G, Hewitt LC, Fazzi GE, Vos AM, Renaud F, Yoshikawa T, Oshima T, Tomezzoli A, de Manzoni G, Arai T, Kushima R, Carneiro F, Grabsch HI. Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer. Gastric Cancer. 2020 Sep;23(5):765-779.（共同研究） |
| ・ | Kano K, Yamada T, Yamamoto K, Komori K, Watanabe H, Hara K, Shimoda Y, Maezawa Y, Fujikawa H, Aoyama T, Tamagawa H, Yamamoto N, Cho H, Shiozawa M, Yukawa N, Yoshikawa T, Morinaga S, Rino Y, Masuda M, Ogata T, Oshima T. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer. Ann Surg Oncol. 2020 Ann Surg Oncol. 2020 Oct;27(11):4235-4247. |
| ・ | Akihiro Suzuki , Hiroto Katoh , Daisuke Komura, Miwako Kakiuchi, Amane Tagashira, Shogo Yamamoto , Kenji Tatsuno, Hiroki Ueda, Genta Nagae, Shiro Fukuda, Takayoshi Umeda, Yasushi Totoki, Hiroyuki Abe, Tetsuo Ushiku, Tetsuya Matsuura, Eiji Sakai, Takashi Ohshima, Sachiyo Nomura, Yasuyuki Seto, Tatsuhiro Shibata, Yasushi Rino, Atsushi Nakajima, Masashi Fukayama, Shumpei Ishikawa, Hiroyuki Aburatani. Defined Lifestyle and Germline Factors Predispose Asian Populations to Gastric Cancer. Sci adv. 2020 May 6;6(19):eaav9778.（共同研究） |
| ・ | Fujikawa H, Koumori K, Watanabe H, Kano K, Shimoda Y, Aoyama T, Yamada T, Hiroshi T, Yamamoto N, Cho H, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Masuda M, Ogata T, Oshima T. The Clinical Significance of Lymphovascular Invasion in Gastric Cancer. In Vivo. 2020 May-Jun;34(3):1533-1539. |
| ・ | Yamada T, Hayashi T, Inokuchi Y, Hayashi K, Watanabe H, Komori K, Kano K, Shimoda Y, Fujikawa H, Shiozawa M, Morinaga S, Rino Y, Masuda M, Ogata T, Oshima T. Impact of the Neutrophil-to-Lymphocyte Ratio on the Survival of Patients with Gastric Cancer Treated with Nivolumab Monotherapy. Target Oncol. 2020 Apr 21. doi: 10.1007/s11523-020-00716-y. [Epub ahead of print] |
| ・ | Kumazu Y, Hayashi T, Yoshikawa T, Yamada T, Hara K, Shimoda Y, Nakazono M, Nagasawa S, Shiozawa M, Morinaga S, Rino Y, Masuda M, Ogata T, Oshima T. Risk factors analysis and stratification for microscopically positive resection margin in gastric cancer patients. BMC Surg. 2020 May 7;20(1):95. |
| ・ | Kawazoe A, Yamaguchi K, Yasui H, Negoro Y, Azuma M, Amagai K, Hara H, Baba H, Tsuda M, Hosaka H, Kawakami H, Oshima T, Omuro Y, Machida N, Esaki T, Yoshida K, Nishina T, Komatsu Y, Han SR, Shiratori S, Shitara K. Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study. Eur J Cancer. 2020 Apr;129:97-106.（共同研究） |
| ・ | Shimoda Y, Yamada T, Komori K, Watanabe H, Osakabe H, Kano K, Fujikawa H, Hayashi T, Cho H, Shiozawa M, Yoshikawa T, Morinaga S, Ota Y, Katsumata K, Tsuchida A, Ogata T and Oshima T. Effect of Muscle Mass Loss After Esophagectomy on Prognosis of Oesophageal Cancer.Anticancer Res. 2020 Mar;40(3):2275-2281. |
| ・ | Watanabe H, Hayashi T, Komori K, Hara K, Maezawa Y, Kano K, Shimoda Y, Fujikawa H, Aoyama T, Yamada T, Yamamoto N, Cho H, Ito H, Shiozawa M, Yukawa N, Morinaga S, Yoshikawa T, Rino Y, Masuda M, Ogata T, Oshima T. Impact of Postoperative Complications on Recurrence in Patients With Stage II/III Gastric Cancer Who Received Adjuvant Chemotherapy With S-1. Anticancer Res. 2020 Mar;40(3):1683-1690. |
| ・ | Hara K, Aoyama T, Yamada T, Nakazono M, Nagasawa S, Shimoda Y, Kumazu Y, Numata M, Hayashi T, Tamagawa H, Shiozawa M, Morinaga S, Yukawa N, Rino Y, Masuda M, Ogata T, Oshima T. The Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Advanced Gastric Cancer. Anticancer Res. 2020 Mar;40(3):1503-1512. |
| ・ | Kumazu Y, Oba K, Hayashi T, Yamada T, Hara K, Osakabe H, Shimoda Y, Nakazono M, Nagasawa S, Rino Y, Masuda M, Ogata T, Yoshikawa T, Oshima T. Relationship Between the Waiting Times for Surgery and Survival in Patients with Gastric Cancer. World J Surg. 2020 Apr;44(4):1209-1215. |
| ・ | Kano K, Sakamaki K, Oue N, Kimura Y, Hashimoto I, Hara K, Maezawa Y, Aoyama T, Fujikawa H, Hiroshima Y, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Cho H, Ito H, Shiozawa M, Yukawa N, Yoshikawa T, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T. Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer Patients Who Received Adjuvant S-1 Chemotherapy. In Vivo. 2020 Jan-Feb;34(1):461-467. |
| ・ | Yamada T, Kano K, Fujikawa H, Komori K, Watanabe H, Shimoda Y, Shiozawa M, Morinaga S, Aoyama T, Numata M, Tamagawa H, Rino Y, Masuda M, Ogata T, Oshima T. Is sufficient experience performing open gastrectomies necessary to start laparoscopic distal gastrectomy training? Asian J Endosc Surg. 2020 Nov 24. Online ahead of print. |
| ・ | Hara K, Aoyama T, Hayashi T, Nakazono M, Nagasawa S, Shimoda Y, Kumazu Y, Numata M, Yamada T, Tamagawa H, Shiozawa M, Morinaga S, Yukawa N, Rino Y, Masuda M, Ogata T, Oshima T. Postoperative D-dimer elevation affects tumor recurrence and the long-term survival in gastric cancer patients who undergo gastrectomy. Int J Clin Oncol. 2020 Apr;25(4):584-594. |
| ・ | Oneyama M, Sakamoto N, Oue N, Kimura Y, Hiroshima Y, Hashimoto I, Hara K, Maezawa Y, Kano K, Aoyama T, Fujikawa H, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Cho H, Ito H, Yukawa N, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Masuda M, Miyagi Y, Yasui W, Oshima T. Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy. Anticancer Res. 2019 Dec;39(12):6567-6573. |
| ・ | Maezawa Y, Sakamaki K, Oue N, Kimura Y, Hashimoto I, Hara K, Kano K, Aoyama T, Hiroshima Y, Yamada T, Yamamoto N, Ogata T, Ito H, Cho H, Shiozawa M, Yoshikawa T, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T. High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.J Cancer Res Clin Oncol. 2019 Nov 21. doi: 10.1007/s00432-019-03087-8. [Epub ahead of print] |
| ・ | Hashimoto I, Sakamaki K, Oue N, Kimura Y, Hiroshima Y, Hara K, Maezawa Y, Kano K, Aoyama T, Yamada T, Yamamoto N, Ogata T, Ito H, Shiozawa M, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T. Clinical Significance of PRKCI Gene Expression in Cancerous Tissue in Patients With Gastric Cancer. Anticancer Res. 2019 Oct;39(10):5715-5720. |
| ・ | Hiroshima Y, Kasajima R, Kimura Y, Komura D, Ishikawa S, Ichikawa Y, Bouvet M, Yamamoto N, Oshima T, Morinaga S, Singh SR, Hoffman RM, Endo I, Miyagi Y. Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma. Cancer Lett. 2020 Jan 28;469:217-227.（共同研究） |
| ・ | Hara K, Aoyama T, Hayashi T, Nakazono M, Nagasawa S, Shimoda Y, Kumazu Y, Numata M, Yamada T, Tamagawa H, Shiozawa M, Morinaga S, Yukawa N, Rino Y, Masuda M, Ogata T, Oshima T. Postoperative D-dimer elevation affects tumor recurrence and the long-term survival in gastric cancer patients who undergo gastrectomy. Int J Clin Oncol. 2019 Dec 21. doi: 10.1007/s10147-019-01603-x. [Epub ahead of print] |
| ・ | Kano K, Aoyama T, Maezawa Y, Hayashi T, Yamada T, Tamagawa H, Sato T, Cho H, Yoshikawa T, Rino Y, Masuda M, Oshima T, Ogata T. Postoperative Level of C-Reactive Protein Is a Prognosticator After Esophageal Cancer Surgery With Perioperative Steroid Therapy and Enhanced Recovery After Surgery Care. In Vivo. 2019 Mar-Apr;33(2):587-594. |
| ・ | Yamada T, Kumazu Y, Nakazono M, Hara K, Nagasawa S, Shimoda Y, Hayashi T, Rino Y, Masuda M, Shiozawa M, Morinaga S, Ogata T, Oshima T. Feasibility and safety of laparoscopy-assisted distal gastrectomy performed by trainees supervised by an experienced qualified surgeon. Surg Endosc. 2019 Apr 9. doi: 10.1007/s00464-019-06786-y. [Epub ahead of print] |
| ・ | Hara K, Hayashi T, Nakazono M, Nagasawa S, Shimoda Y, Kumazu Y, Yamada T, Yamamoto N, Shiozawa M, Morinaga S, Yoshikawa T, Rino Y, Masuda M, Ogata T, Oshima T. An easy and reliable method to close Petersen's defect using barbed suture to prevent internal hernia from developing after gastrectomy with Roux-en-Y reconstruction. Asian J Endosc Surg. 2019 Jul 12. doi: 10.1111/ases.12732. [Epub ahead of print] |
| ・ | Maezawa Y, Aoyama T, Kano K, Tamagawa H, Numata M, Hara K, Murakawa M, Yamada T, Sato T, Ogata T, Oshima T, Yukawa N, Yoshikawa T, Masuda M, Rino Y. Impact of the Age-adjusted Charlson comorbidity index on the short- and long-term outcomes of patients undergoing curative gastrectomy for gastric cancer. J Cancer. 2019 Aug 29;10(22):5527-5535. |
| ・ | Aoyama T, Yoshikawa T, Maezawa Y, Segami K, Kano K, Numata M, Yamada T, Tamagawa H, Fujikawa H, Komori K, Hayashi T, Sato T, Yukawa N, Rino Y, Masuda M, Ogata T, Cho H, Oshima T. Influence of Postoperative Surgical Complications After Gastrectomy on Body Weight and Body Composition Changes in Patients With Gastric Cancer. Anticancer Res. 2019 Feb;39(2):1073-1078. |
| ・ | Aoyama T, Maezawa Y, Yoshikawa T, Segami K, Kano K, Hayashi T, Yamada T, Numata M, Goda M, Tamagawa H, Sato T, Yukawa N, Rino Y, Masuda M, Ogata T, Cho H, Oshima T. Comparison of Weight and Body Composition After Gastrectomy Between Elderly and Non-elderly Patients With Gastric Cancer. In Vivo. 2019 Jan-Feb;33(1):221-227. |
| ・ | Okamoto H, Yoshimatsu Y, Tomizawa T, Kunita A, Takayama R, Morikawa T, Komura D, Takahashi K, Oshima T, Sato M, Komai M, Podyma-Inoue KA, Uchida H, Hamada H, Fujiu K, Ishikawa S, Fukayama M, Fukuhara T, Watabe T. Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma. Sci Rep. 2019 Feb 4;9(1):1281.（共同研究） |
| ・ | Yoshikawa T, Aoyama T, Sakamaki K, Oshima T, Lin J, Zhang S, Sapari NS, Soong R, Tan I, Chan XB, Bottomley D, Hewitt LC, Arai T, Teh BT, Epstein D, Ogata T, Kameda Y, Miyagi Y, Tsuburaya A, Morita S, Grabsch HI, Tan P. Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer. J Cancer. 2019 Aug 28;10(21):5130-5138.（共同研究） |
| ・ | Aoyama T, Yoshikawa T, Maezawa Y, Kano K, Hara K, Sato T, Hayashi T, Yamada T, Cho H, Ogata T, Tamagawa H, Yukawa N, Rino Y, Masuda M, Oshima T. A Comparison of the Body Composition Changes Between Laparoscopy-assisted and Open Total Gastrectomy for Gastric Cancer. In Vivo. 2018 Nov-Dec;32(6):1513-1518. |
| ・ | Aoyama T, Maezawa Y, Yoshikawa T, Segami K, Kano K, Hayashi T, Yamada T, Numata M, Goda M, Tamagawa H, Sato T, Yukawa N, Rino Y, Masuda M, Ogata T, Cho H, Oshima T. Comparison of Weight and Body Composition After Gastrectomy Between Elderly and Non-elderly Patients With Gastric Cancer. In Vivo. 2019 Jan-Feb;33(1):221-227. |
| ・ | Kano K, Aoyama T, Yoshikawa T, Maezawa Y, Nakajima T, Hayashi T, Yamada T, Sato T, Oshima T, Rino Y, Masuda M, Cho H, Ogata T. The Negative Survival Impact of Infectious Complications After Surgery is Canceled Out by the Response of Neoadjuvant Chemotherapy in Patients with Esophageal Cancer. Ann Surg Oncol. 2018 Jul;25(7):2034-2043. |
| ・ | Suzuki Y, OshimaT, Yoshihara K, Sakamaki K, Aoyama T, Cho H, Shiozawa M, Yoshikawa T, Rino Y, Imada T, Masuda M, Clinical significance of SPARC gene expression in patients with stage II/III gastric cancer, after curative resection and adjuvant chemotherapy with S-1. Oncol Lett. 2018 May;15(5):7335-7343.（共同研究） |
| ・ | Maezawa Y, Aoyama T, Yamada T, Kano K, Hayashi T, Sato T, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T. Priority of lymph node dissection for proximal gastric cancer invading the greater curvature. Gastric Cancer. 2018 May;21(3):569-572. |
| ・ | Segami K, Aoyama T, Kano K, Maezawa Y, Nakajima T, Ikeda K, Sato T, Fujikawa H, Hayashi T, Yamada T, Oshima T, Yukawa N, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T. Risk factors for severe weight loss at 1 month after gastrectomy for gastric cancer. Asian J Surg. 2018 Jul;41(4):349-355. |
| ・ | Oue N, Yamamoto Y, Oshima T, Asai R, Ishikawa A, Uraoka N, Sakamoto N, Sentani K, Yasui W. Overexpression of the Transmembrane Protein IQGAP3 Is Associated with Poor Survival of Patients with Gastric Cancer. Pathobiology. 2018;85(3):192-200.（共同研究） |